Barata PC, Grier AL. Re: Final Overall Survival and Safety Analyses of the Phase III PSMAfore Trial of [(177)Lu]Lu-PSMA-617 Versus Change of Androgen Receptor Pathway Inhibitor in Taxane-Naive Patients with Metastatic Castration-Resistant Prostate Cancer. Eur Urol 2025 Dec 19:S0302-2838(25)04858-4. doi: 10.1016/j.eururo.2025.
PMID: 41421925